STOCK TITAN

iCAD to Participate at the 11th Annual LifeSci Partners Virtual Corporate Access Event

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

iCAD, a leader in medical technology, announced participation in the 11th Annual LifeSci Partners Corporate Access Event from January 5-7, 2022. The company's President and incoming CEO, Stacey Stevens, will join a panel titled “Med Tech / Digital Tools: What's the Mindset for 2022?” on January 5 at 2:00 pm ET. This virtual event will highlight key topics in life sciences and feature discussions with industry experts and company management teams. For more details, interested parties can register for the event online.

Loading...
Loading translation...
Argus Session date unavailable
+5.53% session move Open Argus
Details

News Market Reaction – ICAD

The recorded move for ICAD in the trading session of this news was +5.53%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

Company’s President and incoming CEO to participate in a panel discussion titled “Med Tech / Digital Tools: What's the Mindset for 2022?” on January 5, 2022 at 2:00 pm ET

NASHUA, N.H., Dec. 23, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will attend the 11th Annual LifeSci Partners Corporate Access Event, being held virtually from January 5th to 7th, 2022.

Stacey Stevens, President and incoming CEO of iCAD, will participate in a panel discussion titled “Med Tech / Digital Tools: What's the Mindset for 2022?” on Wednesday, January 5th at 2:00 pm ET.

Please register for the event and confirm your interest in meeting with iCAD management here.

The LifeSci Corporate Access Event will feature innovative privately held and publicly traded biotechnology, medical technology, pharmaceutical, life sciences, and digital health companies from across the globe. The event will include meetings with company senior management teams and panel discussions featuring KOLs, CEOs, specialized investors, and healthcare experts, highlighting the most relevant topics impacting today’s life sciences industry.

About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

Contact:
Media Inquiries:
Jessica Burns, iCAD
+1-201-423-4492
jburns@icadmed.com

Investor Relations:
Brian Ritchie, LifeSci Advisors
+ 1-212-915-2578
britchie@lifesciadvisors.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date and time of iCAD's panel discussion at the LifeSci Partners Event?

iCAD's panel discussion will take place on January 5, 2022, at 2:00 pm ET.

Who will represent iCAD at the LifeSci Corporate Access Event?

Stacey Stevens, iCAD's President and incoming CEO, will represent the company.

What is the theme of the panel discussion featuring iCAD at the event?

The theme of the panel discussion is “Med Tech / Digital Tools: What's the Mindset for 2022?”

When does the 11th Annual LifeSci Partners Corporate Access Event start?

The event starts on January 5, 2022, and runs until January 7, 2022.

How can I register for the LifeSci Partners Corporate Access Event?

Interested individuals can register for the event by visiting the registration link provided in the press release.

Keep reading